您的位置: 首页 > 农业专利 > 详情页

Methods of Identifying and Treating Patient Populations Amenable to Cancer Immunotherapy
专利权人:
The Regents of the University of California
发明人:
Matthew Spitzer,Lawrence Fong
申请号:
US16479211
公开号:
US20190378594A1
申请日:
2018.01.19
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Methods for identifying cancer patients amenable to anti-cancer immunotherapy are provided along with methods of monitoring cancer therapy. Also provided are methods of treating cancer patients amenable to anti-cancer immunotherapy. The methods involve determining the level of CD127<;low>;PD-1<;low>;T cells. The patients are treated with an immune checkpoint inhibitor, such as an anti-CTLA-4 antibody, e.g. ipilimumab.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充